{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:51Z","timestamp":1786985091563,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.beem.2025.101978","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T04:54:46Z","timestamp":1738040086000},"page":"101978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of primary hyperparathyroidism with pituitary adenoma and management issues"],"prefix":"10.1016","volume":"39","author":[{"given":"Liza","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.beem.2025.101978_bib1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.beem.2025.101978_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000491037","article-title":"Familial and hereditary forms of primary hyperparathyroidism","volume":"51","author":"Cetani","year":"2019","journal-title":"Parathyr Disord"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cen.14706","article-title":"Molecular genetic testing in the management of pituitary disease","volume":"97","author":"Coopmans","year":"2022","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2025.101978_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000371819","article-title":"MEN1, MEN4, and carney complex: pathology and molecular genetics","volume":"103","author":"Schernthaner-Reiter","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ecl.2020.05.005","article-title":"Update on the genetics of pituitary tumors","volume":"49","author":"Barry","year":"2020","journal-title":"Endocrinol Metab Clin"},{"issue":"8","key":"10.1016\/j.beem.2025.101978_bib6","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1210\/clinem\/dgac162","article-title":"MEN4, the MEN1 mimicker: a case series of three phenotypically heterogenous patients with unique CDKN1B mutations","volume":"107","author":"Seabrook","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.101978_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-19-0522","article-title":"Whole genome sequencing of apparently mutation-negative MEN1 patients","volume":"182","author":"Backman","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.101978_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12020-019-01932-x","volume":"65","author":"K\u00f6vesdi","year":"2019","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.beem.2025.101978_bib10","first-page":"1","article-title":"Familial states of primary hyperparathyroidism: an update","author":"Cetani","year":"2024","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib11","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous dysplasia\/McCune-Albright syndrome: a rare, mosaic disease of G\u03b1 s activation","volume":"41","author":"Boyce","year":"2020","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4158\/EP12301.OR","article-title":"Fibrous dysplasia of bone associated with primary hyperparathyroidism","volume":"19","author":"Turcu","year":"2013","journal-title":"Endocr Pract"},{"issue":"10","key":"10.1016\/j.beem.2025.101978_bib14","doi-asserted-by":"crossref","first-page":"E2029","DOI":"10.1210\/jc.2014-1291","article-title":"McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient","volume":"99","author":"Vasilev","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101978_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1530-891X(20)44469-6","article-title":"MD. McCune-Albright syndrome and primary hyperparathyroidism: an unsusual case presenting with coexisting brown tumors and fibrous dysplasia","volume":"23","author":"Brown","year":"2017","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1210\/jc.2006-1944","article-title":"Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas","volume":"92","author":"Perren","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2025.101978_bib17","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"24","author":"Thakker","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/edrv-8-4-391","article-title":"Familial multiple endocrine neoplasia type I: a new look at pathophysiology","volume":"8","author":"Brandi","year":"1987","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2265.1997.3311122.x","article-title":"Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types","volume":"47","author":"Corbetta","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101978_bib21","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.56.P623","article-title":"Frequency of multiple endocrine neoplasia-1 in patients with primary hyperparathyroidism","author":"Bilginer","year":"2018","journal-title":"Endocr Abstr"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2265.1984.tb00070.x","article-title":"Screening for multiple endocrine neoplasia syndrome (type 1) in patients with primary hyperparathyroidism","volume":"20","author":"Muhr","year":"1984","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2025.101978_bib23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.beem.2025.101978_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-50","article-title":"Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up","volume":"8","author":"Twigt","year":"2013","journal-title":"Orphanet J rare Dis"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/cen.14945","article-title":"Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism","volume":"99","author":"Mathew","year":"2023","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101978_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","article-title":"Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; a clinico-pathologic challenge. The MD Anderson case series and review of the literature","volume":"31","author":"Christakis","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.beem.2025.101978_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00423-019-01751-8","article-title":"The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery","volume":"404","author":"Taterra","year":"2019","journal-title":"Lange'S Arch Surg"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2025.101978_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11102-013-0462-8","article-title":"Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening","volume":"17","author":"Nunes","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2025.101978_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fendo.2019.00837","article-title":"Clinical relevance of genetic analysis in patients with pituitary adenomas: a systematic review","volume":"10","author":"Van den Broek","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2025.101978_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the groupe d\u2032\u00e9tude des tumeurs endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2025.101978_bib34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/thy.2000.10.1001","article-title":"Treatment of a thyrotropinoma with octreotide-LAR in a patient with multiple endocrine neoplasia\u20141","volume":"10","author":"Taylor","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2025.101978_bib35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/BF03343929","article-title":"Loss of heterozygosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas","volume":"24","author":"Asteria","year":"2001","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.humpath.2008.06.013","article-title":"Multiple endocrine neoplasia type 1\u2013associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example","volume":"40","author":"Scheithauer","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beem.2025.101978_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2020.100242","article-title":"Malignancy course of pituitary adenoma in MEN1 syndrome: clinical-neuroradiological signs","volume":"7","author":"Incandela","year":"2020","journal-title":"Eur J Radiol Open"},{"issue":"9","key":"10.1016\/j.beem.2025.101978_bib38","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 Study Group (DMSG)","volume":"100","author":"De Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Members of Groupe d\u2019Etude des N\u00e9oplasies Endocriniennes Multiples*. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3171\/2020.1.JNS193538","article-title":"Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience","volume":"134","author":"Cohen-Cohen","year":"2020","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib41","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/EJE-21-0630","article-title":"Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study","volume":"185","author":"Le Bras","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib42","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.101978_bib43","doi-asserted-by":"crossref","first-page":"e1482","DOI":"10.1210\/clinem\/dgae055","article-title":"Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population and literature review","volume":"109","author":"Chevalier","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12020-023-03497-2","article-title":"Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome","volume":"82","author":"Ruggeri","year":"2023","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib45","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0411","article-title":"Multiple endocrine neoplasia type 4: a new member of the MEN family","volume":"12","author":"Singeisen","year":"2023","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib46","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","article-title":"Germline CDKN1B loss-of-function variants cause pediatric Cushing\u2019s disease with or without an MEN4 phenotype","volume":"105","author":"Chasseloup","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2025.101978_bib47","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical features of multiple endocrine neoplasia type 4: novel pathogenic variant and review of published cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib48","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/endrev\/bnad009","article-title":"Molecular and clinical spectrum of primary hyperparathyroidism","volume":"44","author":"Jha","year":"2023","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib49","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"D\u00e9nes","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2025.101978_bib50","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.beem.2025.101978_bib51","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case report of a prolactinoma in a patient with a novel MAX mutation and bilateral pheochromocytomas","volume":"1","author":"Roszko","year":"2017","journal-title":"J Endocr Soc"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib52","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1530\/ERC-18-0065","article-title":"Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions","volume":"25","author":"Daly","year":"2018","journal-title":"Endocr-Relat Cancer"},{"issue":"8","key":"10.1016\/j.beem.2025.101978_bib53","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.21292","article-title":"Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families","volume":"31","author":"Igreja","year":"2010","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib54","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2006-2513","article-title":"Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families","volume":"92","author":"Daly","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.101978_bib55","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/jc.2012-4029","article-title":"Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas","volume":"98","author":"Pardi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib56","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.2011.04269.x","article-title":"Spanish MEN1 Group. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain","volume":"76","author":"Belar","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2025.101978_bib57","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers","volume":"100","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101978_bib58","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s40618-017-0725-8","article-title":"Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic","volume":"40","author":"Marques","year":"2017","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib59","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients","volume":"22","author":"Rostomyan","year":"2015","journal-title":"Endocr-Relat Cancer"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib60","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1210\/clinem\/dgaa040","article-title":"Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors","volume":"105","author":"Marques","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101978_bib61","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1210\/jc.2001-012022","article-title":"Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome","volume":"87","author":"Akintoye","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib62","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2013-3826","article-title":"Acromegaly and mccune-albright syndrome","volume":"99","author":"Salenave","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.101978_bib63","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1210\/jc.2012-1274","article-title":"Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome","volume":"97","author":"Vortmeyer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101978_bib64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11060-010-0461-9","article-title":"McCune\u2013Albright syndrome: surgical and therapeutic challenges in GH-secreting pituitary adenomas","volume":"104","author":"Madsen","year":"2011","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib65","first-page":"1128","article-title":"Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein","volume":"79","author":"Gessl","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101978_bib66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.beem.2025.101978_bib67","article-title":"Baseline renal dysfunction determines mortality following parathyroidectomy in primary hyperparathyroidism: analysis of Indian PHPT registry","author":"Das","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.beem.2025.101978_bib68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00774-020-01142-w","article-title":"Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry","volume":"39","author":"Arya","year":"2021","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.101978_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2014.11.004","article-title":"Pituitary tumors","volume":"44","author":"Melmed","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib70","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.beem.2012.01.002","article-title":"Subclinical hyperfunctioning pituitary adenomas: the silent tumors","volume":"26","author":"Cooper","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101978_bib71","series-title":"Diagnostic Protocols in Endocrinology","first-page":"1","article-title":"Endocrinology Evaluation Protocol: Pituitary and Hypothalamus","author":"Gupta","year":"2024"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.04.002","article-title":"Management of pituitary incidentaloma","volume":"33","author":"Boguszewski","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib73","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1210\/clinem\/dgab748","article-title":"Nonfunctioning pituitary microadenomas: should imaging interval be extended? A large single-center cohort study","volume":"107","author":"Han","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib74","doi-asserted-by":"crossref","first-page":"829","DOI":"10.5114\/aoms\/147737","article-title":"Multiple endocrine neoplasia type 1 with ectopic parathyroid adenoma","volume":"18","author":"Liu","year":"2022","journal-title":"Arch Med Sci AMS"},{"key":"10.1016\/j.beem.2025.101978_bib75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10689-015-9840-x","article-title":"Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome","volume":"15","author":"Tonelli","year":"2016","journal-title":"Fam Cancer"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib76","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4174\/astr.2016.91.6.323","article-title":"Multiple endocrine neoplasia type 1 with anterior mediastinal parathyroid adenoma: successful localization using Tc-99m sestamibi SPECT\/CT","volume":"91","author":"Park","year":"2016","journal-title":"Ann Surg Treat Res"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib77","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4158\/EP-2018-0003","article-title":"Imaging localization and surgical approach in the management of ectopic parathyroid adenomas","volume":"24","author":"Parikh","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2025.101978_bib78","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00268-012-1451-1","article-title":"Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?","volume":"36","author":"Nilubol","year":"2012","journal-title":"World J Surg"},{"issue":"10","key":"10.1016\/j.beem.2025.101978_bib79","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamaoto.2018.1671","article-title":"Preoperative imaging techniques in primary hyperparathyroidism: a review","volume":"144","author":"Bunch","year":"2018","journal-title":"JAMA Otolaryngol\u2013Head Neck Surg"},{"key":"10.1016\/j.beem.2025.101978_bib80","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","article-title":"A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism","volume":"19","author":"Cheung","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib81","first-page":"127","article-title":"Comparison of SPET\/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: a meta-analysis","volume":"18","author":"Wei","year":"2015","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.beem.2025.101978_bib82","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00423-016-1425-0","article-title":"Use of PET tracers for parathyroid localization: a systematic review and meta-analysis","volume":"401","author":"Kluijfhout","year":"2016","journal-title":"Lange'S Arch Surg"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib83","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/cen.14875","article-title":"Comparison of 4D computed tomography and F-18 fluorocholine PET for localisation of parathyroid lesions in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"99","author":"Patel","year":"2023","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2025.101978_bib84","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","article-title":"A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003","volume":"132","author":"Ruda","year":"2005","journal-title":"Otolaryngol\u2014Head Neck Surg"},{"issue":"11","key":"10.1016\/j.beem.2025.101978_bib85","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.21037\/gs-23-232","article-title":"The role of 18F-fluoromethylcholine-positron emission tomography-computed tomography for preoperative localization of hyperfunctioning parathyroid glands with special emphasis on multiglandular disease: a retrospective cohort study","volume":"12","author":"Murad","year":"2023","journal-title":"Gland Surg"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib86","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jamaoto.2022.0271","article-title":"Advanced computed tomographic localization techniques for primary hyperparathyroidism: a systematic review and meta-analysis","volume":"148","author":"Kattar","year":"2022","journal-title":"JAMA Otolaryngol\u2013Head Neck Surg"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib87","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/lary.21783","article-title":"Parathyroid localization with modified 4D-computed tomography and ultrasonography for patients with primary hyperparathyroidism","volume":"121","author":"Kutler","year":"2011","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.beem.2025.101978_bib88","doi-asserted-by":"crossref","first-page":"T119","DOI":"10.1530\/ERC-17-0199","article-title":"The future: genetics advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Agarwal","year":"2017","journal-title":"Endocr-Relat Cancer"},{"issue":"1-2","key":"10.1016\/j.beem.2025.101978_bib89","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib90","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2025.101978_bib91","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4158\/EP10379.RA","article-title":"Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice","volume":"17","author":"Newey","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2025.101978_bib92","first-page":"1","article-title":"Multiple endocrine neoplasia type 1","volume":"1","author":"Marini","year":"2006","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.beem.2025.101978_bib93","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/GIM.0b013e3181be5c97","article-title":"Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors","volume":"11","author":"Falchetti","year":"2009","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.beem.2025.101978_bib94","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/ajco.12046","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"9","author":"Carroll","year":"2013","journal-title":"Asia-Pac J Clin Oncol"},{"key":"10.1016\/j.beem.2025.101978_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"De Laat","year":"2016","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.beem.2025.101978_bib96","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.surg.2020.04.067","article-title":"Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies","volume":"169","author":"Pieterman","year":"2021","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib97","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1210\/clinem\/dgaa142","article-title":"Clinical MEN-1 among a large cohort of patients with acromegaly","volume":"105","author":"Nachtigall","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101978_bib98","doi-asserted-by":"crossref","first-page":"dgae268","DOI":"10.1210\/clinem\/dgae268","article-title":"Increased prevalence of germline pathogenic CHEK2 variants in individuals with pituitary adenomas","author":"De Sousa","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101978_bib99","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.surg.2020.08.021","article-title":"Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: a meta-analysis","volume":"169","author":"Nastos","year":"2021","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.beem.2025.101978_bib100","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"DutchMEN1 Study Group. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2025.101978_bib101","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-015-0696-5","article-title":"Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to multiple endocrine neoplasia syndrome type 1 (MEN1)","volume":"52","author":"Giusti","year":"2016","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.beem.2025.101978_bib102","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.eprac.2022.02.010","article-title":"The importance of periodical screening for primary hyperparathyroidism in a pituitary tumor cohort in searching patients with MEN1 and its genetic profile","volume":"28","author":"Damianse","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2025.101978_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101820","article-title":"Unusual and lesser-known rare causes of adult growth hormone deficiency","author":"Das","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:33:00Z","timestamp":1741843980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X25000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521690X25000119"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.101978","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of primary hyperparathyroidism with pituitary adenoma and management issues","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.101978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101978"}}